Author:
Beaudeux Jean-Louis,Giral Philippe,Bruckert Eric,Foglietti Marie-José,Chapman M. John
Abstract
AbstractMatrix metalloproteinases (MMPs), also called matrixins, are proteinases that participate in extracellular matrix remodelling and degradation. Under normal physiological conditions, the activities of MMPs are precisely regulated at the level of transcription, of activation of the pro-MMP precursor zymogens and of inhibition by endogenous inhibitors (tissue inhibitors of metalloproteinases; TIMPs). Alteration in the regulation of MMP activity is implicated in diseases such as cancer, fibrosis, arthritis and atherosclerosis. The pathological effects of MMPs and TIMPs in cardiovascular diseases involve vascular remodelling, atherosclerotic plaque instability and left ventricular remodelling after myocardial infarction. Since excessive tissue remodelling and increased matrix metalloproteinase activity have been demonstrated during atherosclerotic lesion progression (including plaque disruption), MMPs represent a potential target for therapeutic intervention aimed at modification of vascular pathology by restoring the physiological balance between MMPs and TIMPs. This review describes the members of the MMP and TIMP families and discusses the structure, function and regulation of MMP activity; finally, pharmacological approaches to MMP inhibition are highlighted.
Subject
Biochemistry (medical),Clinical Biochemistry,General Medicine
Reference66 articles.
1. Erik - son Genetic diversity in the matrix metallopro - teinase family : effects on function and disease progression;Henney;Ann Acad Sci,2000
2. Doxycycline inhibition of aneurysmal degeneration in an elastase - induced rat model of abdominal aortic aneurysm : preservation of aortic elas - tin associated with suppressed production of kD gela - tinase;Petrinec;J Vasc Surg,1996
3. Far - well SM Doxycycline modulates smooth muscle cell growth , migration , and matrix remodelling after arterial injury;Bendeck;Am J Pathol,2003
4. Vas - salli JD Characterization of the cellular binding site for the urokinase - type plasminogen activator;Estreicher;J Biol Chem,1989
5. Mat - sumoto AH Genetic backgrounds but not sizes of atherosclerotic lesions determine medial destruction in the aortic root of apolipoprotein E - deficient mice Arter - ioscler Thromb Vasc;Shi;Biol,2003
Cited by
141 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献